|
obesity |
18 |
|
humans |
14 |
|
inflammation |
14 |
|
adipose tissue |
13 |
|
animals |
12 |
|
insulin resistance |
12 |
|
mice |
12 |
|
lipocalin-2 |
11 |
|
female |
10 |
|
mice, inbred c57bl |
10 |
|
mitochondrial dysfunction |
10 |
|
atherosclerosis |
9 |
|
male |
9 |
|
metabolism |
9 |
|
sirt1 |
9 |
|
adipocytes - metabolism |
8 |
|
adipokine |
8 |
|
adiponectin |
8 |
|
amino acid sequence |
8 |
|
animal experiment |
8 |
|
biomarker |
8 |
|
breast cancer |
8 |
|
diabetic cardiomyopathy |
8 |
|
endothelium |
8 |
|
gut microbiota |
8 |
|
proto-oncogene proteins c-akt - metabolism |
8 |
|
signal transduction - drug effects |
8 |
|
adult |
7 |
|
aged |
7 |
|
cell membrane - metabolism |
7 |
|
electrophoresis, gel, two-dimensional |
7 |
|
endothelial dysfunction |
7 |
|
exercise |
7 |
|
fatty acid-binding proteins - blood |
7 |
|
gluconeogenesis |
7 |
|
hepatocytes - metabolism |
7 |
|
insulin |
7 |
|
macrophages |
7 |
|
middle aged |
7 |
|
models, biological |
7 |
|
molecular sequence data |
7 |
|
risk factors |
7 |
|
signal transduction |
7 |
|
adaptor protein |
6 |
|
adaptor proteins, signal transducing - genetics - metabolism |
6 |
|
adipocyte |
6 |
|
adipokines |
6 |
|
adipose tissue - chemistry |
6 |
|
adiposity - physiology |
6 |
|
angiogenesis |
6 |
|
biogenesis |
6 |
|
blood glucose - analysis |
6 |
|
body mass index |
6 |
|
cell density |
6 |
|
cell line |
6 |
|
cell proliferation - drug effects |
6 |
|
chemicals and cas registry numbers |
6 |
|
cross-sectional studies |
6 |
|
enzyme activation - drug effects |
6 |
|
escherichia coli - genetics |
6 |
|
fgf21 |
6 |
|
follow-up studies |
6 |
|
gene expression |
6 |
|
glycosylation |
6 |
|
heart |
6 |
|
homeostasis |
6 |
|
hong kong - epidemiology |
6 |
|
hypertension - epidemiology |
6 |
|
hypertriglyceridemia - epidemiology |
6 |
|
likelihood functions |
6 |
|
lipids |
6 |
|
lipocalin |
6 |
|
medical sciences |
6 |
|
metabolic syndrome x - blood - epidemiology - etiology |
6 |
|
metalloporphyrins - pharmacology |
6 |
|
mice, obese |
6 |
|
obesity - epidemiology |
6 |
|
odds ratio |
6 |
|
ph domain and leucine zipper containing 1 (appl1) |
6 |
|
pharmacy and pharmacology environmental studies |
6 |
|
phosphotyrosine interaction |
6 |
|
polymerase chain reaction |
6 |
|
prospective studies |
6 |
|
proteins - metabolism |
6 |
|
proteome |
6 |
|
proteomics - methods |
6 |
|
rats |
6 |
|
sirt3 |
6 |
|
tnf receptor-associated factor 6 - genetics - metabolism |
6 |
|
toxicology and environmental safety |
6 |
|
ubiquitination |
6 |
|
acyl coenzyme a - metabolism |
5 |
|
adaptor proteins, signal transducing - antagonists and inhibitors - genetics - physiology |
5 |
|
adaptor proteins, signal transducing - metabolism |
5 |
|
adiponectin - biosynthesis - metabolism |
5 |
|
adiponectin and adipokine |
5 |
|
affinity chromatography |
5 |
|
aging |
5 |
|
aging - metabolism |
5 |
|
anoxia - metabolism |
5 |
|
antineoplastic activity |
5 |
|
antineoplastic agents - pharmacology |
5 |
|
aorta, thoracic - drug effects - metabolism - physiopathology |
5 |
|
autophagy |
5 |
|
binding, competitive |
5 |
|
bioaccumulation |
5 |
|
biofilm |
5 |
|
biofilms |
5 |
|
biological markers - blood |
5 |
|
biotin |
5 |
|
cardio-renal metabolic syndrome |
5 |
|
cardiovascular disease |
5 |
|
carotid artery diseases - diagnosis |
5 |
|
carotid intima-media thickness |
5 |
|
carrier proteins - metabolism |
5 |
|
cell cycle proteins - metabolism |
5 |
|
cell movement - drug effects |
5 |
|
cells, cultured |
5 |
|
cyp2c9 |
5 |
|
diabetes |
5 |
|
diabetes mellitus, type 2 - enzymology |
5 |
|
drug resistance, fungal |
5 |
|
endothelin-1 - metabolism |
5 |
|
endothelium, vascular - drug effects - metabolism - physiopathology |
5 |
|
endothelium, vascular - drug effects - physiopathology |
5 |
|
energy metabolism |
5 |
|
enos |
5 |
|
exercise responsiveness |
5 |
|
fatty acid-binding proteins - physiology |
5 |
|
fatty-acid-binding proteins |
5 |
|
gene knockdown techniques |
5 |
|
glucose - biosynthesis - metabolism |
5 |
|
glucose dysregulation |
5 |
|
gold compounds - pharmacology |
5 |
|
hepatocytes - enzymology |
5 |
|
humdisease |
5 |
|
hyperglycemia - diagnosis |
5 |
|
hypoxia |
5 |
|
inflammation - immunology - metabolism |
5 |
|
insulin - metabolism |
5 |
|
insulin - pharmacology |
5 |
|
interaction profiling |
5 |
|
ionization time of flight mass spectrometry |
5 |
|
jnk mitogen-activated protein kinases - genetics - metabolism |
5 |
|
lipocalins - genetics - physiology |
5 |
|
liquid chromatography-tan-dem mass spectrometry |
5 |
|
liver - drug effects - injuries - metabolism |
5 |
|
liver glycogen - metabolism |
5 |
|
liver injury |
5 |
|
longevity regulator |
5 |
|
macrophages - metabolism |
5 |
|
mammary neoplasms, experimental - drug therapy |
5 |
|
matrix-assisted laser desorption |
5 |
|
metabolic syndrome |
5 |
|
metabolic syndrome x - blood |
5 |
|
mice, nude |
5 |
|
microbiology |
5 |
|
mitochondria |
5 |
|
mitochondrial proteins - genetics - metabolism |
5 |
|
nerve tissue proteins - metabolism |
5 |
|
nitric oxide - metabolism |
5 |
|
obesity - blood |
5 |
|
obesity - blood - diagnosis |
5 |
|
obesity - metabolism - physiopathology |
5 |
|
obesity - physiopathology |
5 |
|
oncogene proteins - blood |
5 |
|
oncogene proteins - deficiency - genetics - physiology |
5 |
|
oxidative stress |
5 |
|
personalized medicine |
5 |
|
phosphorylation - drug effects |
5 |
|
plasminogen activator inhibitor 1 - biosynthesis |
5 |
|
polyamination |
5 |
|
porphyrin derivative |
5 |
|
protein binding |
5 |
|
protein interaction mapping - methods |
5 |
|
protein structure, tertiary |
5 |
|
proto-oncogene proteins - blood |
5 |
|
reactive oxygen species - metabolism |
5 |
|
recombinant proteins - genetics - metabolism |
5 |
|
rna interference |
5 |
|
rosiglitazone |
5 |
|
signaling |
5 |
|
sirtuin 1 |
5 |
|
sirtuin 3 |
5 |
|
sirtuins - genetics - metabolism |
5 |
|
thiazolidinediones - toxicity |
5 |
|
time factors |
5 |
|
transcription factor ap-1 - genetics - metabolism |
5 |
|
transcription factor yy1 |
5 |
|
uncoupling protein 2 |
5 |
|
2-d dige |
4 |
|
2-de |
4 |
|
28 inflammation in type 2 diabetes |
4 |
|
3t3 cells |
4 |
|
3t3-l1 cells |
4 |
|
active transport, cell nucleus - drug effects |
4 |
|
adaptive thermogenesis |
4 |
|
adaptor proteins, signal transducing |
4 |
|
adipocyte precursor cells |
4 |
|
adipogenesis |
4 |
|
adipokines - blood |
4 |
|
adipokines - metabolism - pharmacology |
4 |
|
adiponectin - chemistry |
4 |
|
adiponectin - genetics - pharmacology |
4 |
|
adiponectin - pharmacology |
4 |
|
adipopharmacology |
4 |
|
adipose remodeling |
4 |
|
adipose tissue, brown - metabolism |
4 |
|
amp-activated protein kinases |
4 |
|
angiopoietin-like proteins |
4 |
|
angiopoietins |
4 |
|
anti-oxidant activity |
4 |
|
antioxidants - physiology |
4 |
|
apolipoprotein |
4 |
|
apoptosis - drug effects |
4 |
|
apoptosis - drug effects - physiology |
4 |
|
asian continental ancestry group |
4 |
|
bacteria - drug effects |
4 |
|
base sequence |
4 |
|
beiging |
4 |
|
beta catenin - metabolism |
4 |
|
biofilms - drug effects - growth and development |
4 |
|
blood proteins - physiology |
4 |
|
blood vessels - drug effects - metabolism |
4 |
|
blood-brain barrier |
4 |
|
blotting, northern |
4 |
|
breast carcinogenesis |
4 |
|
breast neoplasms - metabolism - pathology - therapy |
4 |
|
cancer stem cells |
4 |
|
candida |
4 |
|
candida albicans - genetics - pathogenicity - ultrastructure |
4 |
|
candida glabrata |
4 |
|
candida glabrata - drug effects - genetics - metabolism - physiology |
4 |
|
cardiovascular diseases |
4 |
|
cardiovascular diseases - blood - epidemiology - etiology |
4 |
|
carrier proteins - blood |
4 |
|
carrier proteins - genetics |
4 |
|
cattle |
4 |
|
cell cycle - drug effects |
4 |
|
cell differentiation |
4 |
|
cell line, tumor |
4 |
|
cell nucleus - drug effects - metabolism |
4 |
|
china |
4 |
|
cholesterol |
4 |
|
chromatography, high pressure liquid |
4 |
|
cloning, molecular |
4 |
|
creb-h |
4 |
|
culture media - chemistry - pharmacology |
4 |
|
cyclin d1 - metabolism |
4 |
|
diabetes mellitus, experimental - complications - enzymology - physiopathology |
4 |
|
dietary fats - administration & dosage - pharmacology |
4 |
|
dna, complementary - genetics |
4 |
|
dnmt1 |
4 |
|
drug resistance, fungal - genetics |
4 |
|
drug resistance, multiple, bacterial |
4 |
|
dyslipidaemia |
4 |
|
endothelium, vascular - drug effects - enzymology - physiology |
4 |
|
endothelium, vascular - drug effects - pathology |
4 |
|
endotoxemia |
4 |
|
energy metabolism - drug effects |
4 |
|
eosinophils |
4 |
|
eotaxin |
4 |
|
ets-domain protein elk-1 - biosynthesis |
4 |
|
extracellular signal-regulated map kinases - antagonists & inhibitors - metabolism |
4 |
|
fatty liver |
4 |
|
feeding behavior - drug effects |
4 |
|
fetal blood |
4 |
|
fibroblast growth factor 2 - pharmacology |
4 |
|
fibroblast growth factor 21 |
4 |
|
fibroblast growth factors - metabolism |
4 |
|
fish oil |
4 |
|
fungi - drug effects - physiology |
4 |
|
gene expression profiling |
4 |
|
gene therapy - methods |
4 |
|
genetic vectors |
4 |
|
glucose intolerance - complications - physiopathology |
4 |
|
glucose intolerance - genetics - metabolism |
4 |
|
glucose transport proteins, facilitative - biosynthesis |
4 |
|
glycogen synthase kinase 3 - antagonists & inhibitors - metabolism |
4 |
|
glycoproteins - blood |
4 |
|
heart failure |
4 |
|
hemin |
4 |
|
high-fat diet |
4 |
|
hormones |
4 |
|
host-microbial interactions |
4 |
|
hypertriglyceridemia |
4 |
|
hypoxia-inducible factor 1, alpha subunit - genetics - metabolism |
4 |
|
isoliquiritigenin |
4 |
|
isometric contraction - drug effects - physiology |
4 |
|
ldlr |
4 |
|
lipid metabolism - drug effects |
4 |
|
lipoprotein lipase |
4 |
|
lipoproteins |
4 |
|
liver - drug effects - metabolism - physiopathology |
4 |
|
lysine - chemistry |
4 |
|
mammary tumorigenesis |
4 |
|
map kinase |
4 |
|
map kinase kinase kinases - antagonists & inhibitors - metabolism |
4 |
|
mass spectrometry |
4 |
|
metabolic syndrome x - blood - etiology |
4 |
|
microarray |
4 |
|
mitochondria - drug effects - metabolism |
4 |
|
motor activity - drug effects |
4 |
|
mouse models |
4 |
|
multienzyme complexes - genetics - metabolism |
4 |
|
muscle, skeletal - drug effects - enzymology - physiopathology |
4 |
|
mutagenesis, site-directed |
4 |
|
neovascularization |
4 |
|
neovascularization, physiologic - physiology |
4 |
|
nephrology |
4 |
|
neuroinflammation |
4 |
|
nf-κb pathway |
4 |
|
nitric oxide - biosynthesis |
4 |
|
nitric oxide synthase type iii - drug effects - metabolism |
4 |
|
obesity - blood - complications |
4 |
|
obesity - genetics - metabolism |
4 |
|
periodontal disease |
4 |
|
pharmacy and pharmacology psychology |
4 |
|
phosphorylation |
4 |
|
polyunsaturated fatty acids |
4 |
|
porcine coronary artery angioplasty |
4 |
|
prevalence |
4 |
|
protein 14-3-3 |
4 |
|
protein kinase b |
4 |
|
protein processing, post-translational |
4 |
|
protein-serine-threonine kinases - genetics - metabolism |
4 |
|
raf kinases - antagonists & inhibitors - metabolism |
4 |
|
receptors, adiponectin |
4 |
|
receptors, cell surface - genetics |
4 |
|
recombinant fusion proteins - metabolism |
4 |
|
recombinant proteins - administration & dosage - pharmacology |
4 |
|
regeneration |
4 |
|
resistance |
4 |
|
serum response factor - metabolism |
4 |
|
stress response |
4 |
|
stress, physiological |
4 |
|
thiazolidinediones - pharmacology |
4 |
|
triglycerides - blood |
4 |
|
two-dimensional gel electrophoresis |
4 |
|
type 2 immunity |
4 |
|
umbilical veins |
4 |
|
up-regulation - drug effects |
4 |
|
vascular endothelial growth factor a - pharmacology |
4 |
|
vasodilation - drug effects - physiology |
4 |
|
wif1 demethylation |
4 |
|
wnt/β-catenin signaling |
4 |
|
xenograft model antitumor assays - methods |
4 |
|
6-phytase - chemistry - metabolism |
3 |
|
a-fabp inhibitor |
3 |
|
acetaminophen |
3 |
|
acetylation |
3 |
|
acid phosphatase - chemistry - isolation & purification - metabolism - secretion |
3 |
|
active transport, cell nucleus |
3 |
|
acute liver injury |
3 |
|
adipocytes - drug effects |
3 |
|
adipocytes - drug effects - physiology |
3 |
|
adipocytes - physiology |
3 |
|
adiponectin - chemistry - genetics - metabolism - secretion |
3 |
|
adiponectin - metabolism |
3 |
|
adiponectin - pharmacology - physiology |
3 |
|
adiponectin - physiology |
3 |
|
adipose tissue - metabolism |
3 |
|
ageing |
3 |
|
akt |
3 |
|
alcohol drinking - metabolism |
3 |
|
alpha 2 macroglobulin |
3 |
|
alpha-macroglobulins - physiology |
3 |
|
alu |
3 |
|
amino acid motifs - physiology |
3 |
|
amino acid substitution |
3 |
|
ampk |
3 |
|
angiopoietins - genetics - metabolism |
3 |
|
animal cell |
3 |
|
anti-inflammatory agents - chemical synthesis - chemistry - pharmacology |
3 |
|
anti-oxidant |
3 |
|
antioxidants - chemistry - pharmacology |
3 |
|
apoptosis |
3 |
|
appl1 |
3 |
|
appl2 |
3 |
|
aromatic substituted pyrazoles |
3 |
|
atherosclerosis - enzymology - pathology |
3 |
|
bilirubin |
3 |
|
biological monitoring |
3 |
|
biology |
3 |
|
blood glucose - metabolism |
3 |
|
blood pressure |
3 |
|
blood proteins - chemistry - metabolism |
3 |
|
blotting, western |
3 |
|
breast neoplasms - etiology - metabolism - pathology |
3 |
|
c-jun n-terminal kinase (jnk) |
3 |
|
calorie restriction |
3 |
|
cardiometabolic disease |
3 |
|
cardiovascular diseases - epidemiology |
3 |
|
cardiovascular diseases - etiology |
3 |
|
carnitine o-palmitoyltransferase - antagonists and inhibitors - genetics - metabolism |
3 |
|
carnitine palmitoyltransferase 1a (cpt1a) |
3 |
|
catalysis |
3 |
|
celastrol |
3 |
|
cell aging - physiology |
3 |
|
cell fractionation |
3 |
|
cell nucleus - metabolism |
3 |
|
cell proliferation |
3 |
|
chromatography, affinity |
3 |
|
chromatography, liquid |
3 |
|
circadian rhythm |
3 |
|
conserved sequence |
3 |
|
cpg islands |
3 |
|
culture media - chemistry |
3 |
|
cyclin-dependent kinase 5 |
3 |
|
cyclin-dependent kinase 5 - antagonists and inhibitors - physiology |
3 |
|
cycloheximide |
3 |
|
cytokines |
3 |
|
diabetes mellitus, type 2 - epidemiology |
3 |
|
differentiation |
3 |
|
dimerization |
3 |
|
dna methylation |
3 |
|
dna primers |
3 |
|
drug design |
3 |
|
dyslipidemias - blood |
3 |
|
endothelial cells |
3 |
|
endothelial senescence |
3 |
|
endothelium, vascular - enzymology - metabolism - pathology |
3 |
|
endothelium-dependent hyperpolarization |
3 |
|
endothelium-derived contracting factor |
3 |
|
endotoxin shock |
3 |
|
enzyme inhibitors - metabolism |
3 |
|
epigenesis, genetic |
3 |
|
escherichia coli |
3 |
|
escherichia coli - metabolism |
3 |
|
ethanol |
3 |
|
exerkines |
3 |
|
expression and purification |
3 |
|
extracellular fluid - metabolism |
3 |
|
extracellular matrix proteins - genetics |
3 |
|
fatty acid |
3 |
|
fatty acid-binding proteins - antagonists and inhibitors |
3 |
|
fatty acids - blood |
3 |
|
fatty acids - metabolism |
3 |
|
fatty acids - toxicity |
3 |
|
fatty acids, nonesterified - metabolism |
3 |
|
fatty liver - drug therapy |
3 |
|
fatty liver - etiology - physiopathology - therapy |
3 |
|
fatty liver disease |
3 |
|
fibroblast growth factors - blood |
3 |
|
fibroblasts |
3 |
|
fusion protein |
3 |
|
gene coverage |
3 |
|
gene density |
3 |
|
gene expression regulation - physiology |
3 |
|
gene expression regulation, neoplastic |
3 |
|
genome-wide association study |
3 |
|
glucose - metabolism |
3 |
|
glucose tolerance test |
3 |
|
glycogen synthase kinase 3 - physiology |
3 |
|
glycoproteins - chemistry - isolation & purification - metabolism - secretion |
3 |
|
growth hormone |
3 |
|
guanine nucleotide binding protein |
3 |
|
hdl-cholesterol |
3 |
|
heme oxygenase-1 |
3 |
|
hepatic steatosis |
3 |
|
high fat diet |
3 |
|
hmgb1 |
3 |
|
hormone |
3 |
|
human c1q and tumor necrosis factor related protein 2 (hctrp2) |
3 |
|
human gingival fibroblasts |
3 |
|
human platelet-derived growth factor a |
3 |
|
infection and periodontal disease |
3 |
|
inflammation related diseases |
3 |
|
inflammatory cytokines |
3 |
|
inflammatory mediators |
3 |
|
inflammatory response |
3 |
|
insulin - blood |
3 |
|
insulin resistance - physiology |
3 |
|
insulin sensitivity |
3 |
|
intercellular signaling peptides and proteins |
3 |
|
intercellular signaling peptides and proteins - blood - chemistry - isolation & purification |
3 |
|
intercellular signaling peptides and proteins - genetics |
3 |
|
intervertebral disc degeneration |
3 |
|
isoelectric focusing |
3 |
|
issue 148 |
3 |
|
kinetics |
3 |
|
lactate dehydrogenase |
3 |
|
linkage disequilibrium blocks |
3 |
|
lipid a heterogeneity |
3 |
|
lipid metabolism |
3 |
|
lipopolysaccharide |
3 |
|
lipoprotein lipase - antagonists & inhibitors - genetics - metabolism |
3 |
|
liver |
3 |
|
liver - metabolism |
3 |
|
lkb1 |
3 |
|
macrophage infiltration and polarization |
3 |
|
macrophage polarization |
3 |
|
magnetic resonance spectroscopy |
3 |
|
mammary neoplasms, animal - metabolism - pathology |
3 |
|
mass spectrometry - methods |
3 |
|
mcd diet |
3 |
|
mesenchymal stem cells - chemistry - physiology |
3 |
|
metabolic inflammation |
3 |
|
metabolic syndrome x - blood - diagnosis |
3 |
|
metabolic syndrome x - complications - prevention & control |
3 |
|
methionine - metabolism |
3 |
|
mice, knockout |
3 |
|
mitogen activated protein kinase |
3 |
|
mmps |
3 |
|
molecular structure |
3 |
|
molecular weight |
3 |
|
molybdenum - pharmacology |
3 |
|
mutation |
3 |
|
myeloid-derived suppressor cell |
3 |
|
na+-k+-atpase |
3 |
|
nanomicelles |
3 |
|
nash |
3 |
|
neoplasms, hormone-dependent - metabolism |
3 |
|
nf-κb |
3 |
|
nicotiana tabacum |
3 |
|
nicotinamide |
3 |
|
nitric oxide |
3 |
|
nitric oxide bioavailability |
3 |
|
nlrp3 inflammasome |
3 |
|
obesity - complications |
3 |
|
obesity - complications - metabolism |
3 |
|
obesity, morbid - blood |
3 |
|
p. gingivalis lps |
3 |
|
p25 |
3 |
|
peptide mapping - methods |
3 |
|
phosphorus |
3 |
|
phylogeny |
3 |
|
phytase |
3 |
|
phytate |
3 |
|
pi3k |
3 |
|
pichia - genetics |
3 |
|
pichia pastoris |
3 |
|
plant roots - enzymology |
3 |
|
polyphenols |
3 |
|
porphyromonas gingivalis |
3 |
|
ppar gamma - agonists - metabolism |
3 |
|
ppar gamma - physiology |
3 |
|
precision medicine |
3 |
|
pressure overload |
3 |
|
pro-inflammatory adipokine |
3 |
|
proinflammatory cytokines |
3 |
|
promoter regions, genetic |
3 |
|
protease inhibitors |
3 |
|
protein expression |
3 |
|
protein isoforms |
3 |
|
protein processing, post-translational - drug effects |
3 |
|
protein purification |
3 |
|
protein structure, tertiary - physiology |
3 |
|
proteins - genetics - isolation & purification - metabolism |
3 |
|
proteome - analysis |
3 |
|
proteomics |
3 |
|
purple acid phosphatase |
3 |
|
pyrazoles - chemical synthesis - chemistry - pharmacology |
3 |
|
randomized controlled trials as topic |
3 |
|
receptors, estrogen - metabolism |
3 |
|
recombinant fusion proteins - genetics - isolation & purification - metabolism |
3 |
|
recombinant protein |
3 |
|
recombinant proteins - chemistry |
3 |
|
recombination |
3 |
|
reverse transcriptase polymerase chain reaction |
3 |
|
rna, small interfering |
3 |
|
root exudates |
3 |
|
senescence |
3 |
|
sequence alignment |
3 |
|
sequence alignment - methods |
3 |
|
single-cell rna sequencing |
3 |
|
sirtuin 1 - genetics - metabolism |
3 |
|
smooth muscle cell |
3 |
|
soil |
3 |
|
solanaceae |
3 |
|
soluble guanylyl cyclase |
3 |
|
sp1 transcription factor - physiology |
3 |
|
stilbenes - chemistry - pharmacology |
3 |
|
substrate specificity |
3 |
|
systolic arterial blood pressure |
3 |
|
thrombospondin-1 |
3 |
|
tobacco |
3 |
|
tobacco - enzymology |
3 |
|
toll-like receptor (tlr)-4 |
3 |
|
triglycerides - metabolism |
3 |
|
trypsin - chemistry |
3 |
|
type 2 diabetes |
3 |
|
vascular smooth muscle |
3 |
|
vasodilatation |
3 |
|
wine - analysis |
3 |
|
acetyl-coa carboxylase - metabolism |
2 |
|
acute-phase proteins - metabolism - pharmacology |
2 |
|
adaptor proteins, signal transducing - physiology |
2 |
|
adductor muscle |
2 |
|
adenylyl cyclase |
2 |
|
adiponectin - chemistry - pharmacology |
2 |
|
adiponectin - metabolism - pharmacology |
2 |
|
akt2 |
2 |
|
amp-activated protein kinases - metabolism |
2 |
|
amylin |
2 |
|
amyloid - antagonists & inhibitors - pharmacology - physiology |
2 |
|
amyloid - pharmacology |
2 |
|
animal proteomics |
2 |
|
antioxidants - pharmacology |
2 |
|
aorta |
2 |
|
aorta - metabolism |
2 |
|
arterial stiffness |
2 |
|
artery aging |
2 |
|
biological sciences |
2 |
|
biological transport, active - drug effects |
2 |
|
biomarker discovery |
2 |
|
cadmium |
2 |
|
calcitonin gene-related peptide |
2 |
|
calcitonin gene-related peptide - pharmacology |
2 |
|
calcium overload |
2 |
|
capillarization |
2 |
|
cardiac fibrosis |
2 |
|
cardiac hypertrophy |
2 |
|
cardiovascular surgery |
2 |
|
cell aging |
2 |
|
cell aging - drug effects - genetics |
2 |
|
cell biology |
2 |
|
cell nucleus - enzymology |
2 |
|
cell survival |
2 |
|
chemical fractionation - methods |
2 |
|
chromatography, deae-cellulose - methods |
2 |
|
chromatography, gel - methods |
2 |
|
cl316243 |
2 |
|
coronary artery bypass surgery |
2 |
|
coronary vessels - drug effects - metabolism |
2 |
|
cos cells |
2 |
|
dexamethasone - pharmacology |
2 |
|
dextrans |
2 |
|
diabetic complications |
2 |
|
diastolic heart failure |
2 |
|
diet, high-fat |
2 |
|
dietary fats - pharmacology |
2 |
|
digestive system - cytology |
2 |
|
disease models, animal |
2 |
|
dna, complementary - metabolism |
2 |
|
dose-response relationship, drug |
2 |
|
duodenum |
2 |
|
duodenum - cytology |
2 |
|
early vascular ageing |
2 |
|
electron transport chain |
2 |
|
electrophoresis, polyacrylamide gel |
2 |
|
electrophoretic mobility shift assay |
2 |
|
embryo, nonmammalian |
2 |
|
endothelial cells - drug effects - metabolism |
2 |
|
endothelium-dependent contractions |
2 |
|
enzyme activation |
2 |
|
enzyme inhibitors - pharmacology |
2 |
|
epinephrine |
2 |
|
epinephrine - pharmacology |
2 |
|
er stress |
2 |
|
feedback |
2 |
|
fibrosis |
2 |
|
forskolin - pharmacology |
2 |
|
free radical scavengers - pharmacology |
2 |
|
fsp27 |
2 |
|
gastroenterology |
2 |
|
gene expression - drug effects |
2 |
|
gene expression profiling - methods |
2 |
|
gene expression regulation |
2 |
|
glucose and fatty acid uptake and metabolism |
2 |
|
glucose transporter type 4 - metabolism |
2 |
|
heart failure with preserved ejection fraction |
2 |
|
heat-shock proteins |
2 |
|
heat-shock proteins - metabolism |
2 |
|
heme oxygenase 1 |
2 |
|
hepatopancreas |
2 |
|
high-density fermentation |
2 |
|
hindlimb - metabolism |
2 |
|
hsp20 heat-shock proteins |
2 |
|
human umbilical vein endothelial cells - metabolism |
2 |
|
hydrogen peroxide |
2 |
|
hydrogen-ion concentration |
2 |
|
hyperglycemia - genetics - metabolism |
2 |
|
hyperhomocysteinemia |
2 |
|
hyperinsulinism - genetics - metabolism |
2 |
|
hypertension |
2 |
|
immunohistochemistry |
2 |
|
insulin antagonists - pharmacology |
2 |
|
insulin-like growth factor i - pharmacology |
2 |
|
interleukin-6 |
2 |
|
interleukin-6 - biosynthesis - chemistry - immunology - isolation & purification |
2 |
|
ion channels - deficiency - genetics - metabolism |
2 |
|
islet amyloid polypeptide |
2 |
|
isoelectric point |
2 |
|
isoenzymes - antagonists & inhibitors - genetics - metabolism |
2 |
|
kidney injury |
2 |
|
left ventricular hypertrophy |
2 |
|
lipocalins - metabolism - pharmacology |
2 |
|
lipocalin‐2 |
2 |
|
low abundant protein |
2 |
|
lymphocytes - immunology |
2 |
|
membrane protein |
2 |
|
membrane proteins - biosynthesis - chemistry - physiology |
2 |
|
mesenteric arteries - drug effects - metabolism - physiopathology |
2 |
|
metabolic diseasec |
2 |
|
metabolic disorders |
2 |
|
metallothionein isoform |
2 |
|
methylnicotinamide |
2 |
|
microcirculation |
2 |
|
mitochondrial biogenesis |
2 |
|
mitochondrial proteins - deficiency - genetics - metabolism |
2 |
|
models, animal |
2 |
|
models, genetic |
2 |
|
molecular physiology |
2 |
|
multienzyme complexes - metabolism |
2 |
|
muscle proteins - chemistry |
2 |
|
muscle proteins - genetics - isolation & purification - metabolism |
2 |
|
muscle proteins - metabolism |
2 |
|
muscle proteins - metabolism - physiology |
2 |
|
muscle, skeletal - drug effects - metabolism |
2 |
|
muscle, skeletal - metabolism |
2 |
|
muscle, smooth, vascular - metabolism |
2 |
|
mussel |
2 |
|
myoblasts, skeletal - drug effects - metabolism |
2 |
|
myocardium - metabolism |
2 |
|
myocytes, cardiac - cytology - metabolism |
2 |
|
myocytes, cardiac - metabolism |
2 |
|
myography |
2 |
|
neutrophil |
2 |
|
nf-kappa b - metabolism |
2 |
|
nfκb |
2 |
|
nitric oxide synthase - antagonists & inhibitors - metabolism |
2 |
|
obesity - etiology - metabolism - physiopathology |
2 |
|
oligonucleotide array sequence analysis |
2 |
|
oncogene proteins - metabolism - pharmacology |
2 |
|
organ culture techniques |
2 |
|
oxidation-reduction |
2 |
|
oxidative stress - drug effects - genetics |
2 |
|
p20 |
2 |
|
p53 |
2 |
|
palmitates - metabolism |
2 |
|
pancreas |
2 |
|
pancreas - cytology |
2 |
|
peptide mapping |
2 |
|
perna viridis |
2 |
|
phosphatidylinositol 3-kinases - metabolism |
2 |
|
phospholipase c beta |
2 |
|
phosphopeptides - chemistry |
2 |
|
phosphopeptides - isolation & purification |
2 |
|
phosphoprotein |
2 |
|
phosphoproteins - chemistry |
2 |
|
phosphoproteins - genetics - isolation & purification - metabolism |
2 |
|
phosphorylation ampk |
2 |
|
pichia - genetics - metabolism |
2 |
|
polyethylene glycols - metabolism |
2 |
|
precipitin tests |
2 |
|
prostacyclin |
2 |
|
protein isoforms - metabolism |
2 |
|
protein kinase c - antagonists & inhibitors - metabolism |
2 |
|
protein kinase c-alpha |
2 |
|
protein-serine-threonine kinases - metabolism |
2 |
|
rats, wistar |
2 |
|
reactive oxygen species |
2 |
|
recombinant proteins - biosynthesis - chemistry - immunology - isolation & purification |
2 |
|
recombinant proteins - chemistry - pharmacology |
2 |
|
recombinant proteins - metabolism |
2 |
|
reference values |
2 |
|
regional blood flow |
2 |
|
rna, messenger - metabolism |
2 |
|
sample prefractionation |
2 |
|
seipin |
2 |
|
serine - metabolism |
2 |
|
silent information regulator |
2 |
|
sirtuin |
2 |
|
sirtuin 1 - metabolism |
2 |
|
spontaneously hypertensive rat |
2 |
|
stem cells - cytology |
2 |
|
stomach |
2 |
|
stomach - cytology |
2 |
|
stress |
2 |
|
sus scrofa |
2 |
|
tetrazolium salts - metabolism |
2 |
|
thiazoles - metabolism |
2 |
|
thromboxane-prostanoid receptor |
2 |
|
tissue distribution |
2 |
|
titin |
2 |
|
toll-like receptors |
2 |
|
traditional chinese medicine |
2 |
|
transfection |
2 |
|
tumor necrosis factor-alpha - metabolism |
2 |
|
tumor suppressor protein p53 - metabolism |
2 |
|
type c phospholipases - genetics - metabolism |
2 |
|
uncoupling protein |
2 |
|
vascular endothelial dysfunction |
2 |
|
vascular inflammation |
2 |
|
vasodilation - drug effects |
2 |
|
vasodilator agents - pharmacology |
2 |
|
wat remodeling |
2 |
|
xenopus |
2 |
|
xenopus laevis |
2 |
|
xenopus proteins - physiology |
2 |
|
zebrafish |
2 |
|
5-hydroxytryptamine receptor agonist |
1 |
|
acute-phase proteins - physiology |
1 |
|
adipocyte progenitor |
1 |
|
adiposity |
1 |
|
age |
1 |
|
anti-obesity agents - adverse effects - pharmacology |
1 |
|
anti-obesity drug |
1 |
|
arterial remodelling |
1 |
|
arteries |
1 |
|
atp-sensitive potassium channel opener |
1 |
|
benzazepines - adverse effects - pharmacology |
1 |
|
bone and bones - pathology - radiography |
1 |
|
bone ultrastructure |
1 |
|
breast milk |
1 |
|
cardiometbolic diseases |
1 |
|
cardiovascular diseases - etiology - prevention and control |
1 |
|
caspase inhibitor |
1 |
|
clinical trial |
1 |
|
collagen |
1 |
|
contractile function |
1 |
|
dietary restriction |
1 |
|
disulfide bond |
1 |
|
drug discovery |
1 |
|
elastin |
1 |
|
electron microscopy |
1 |
|
endothelial cell |
1 |
|
endothelium, vascular - drug effects - physiology |
1 |
|
fat depots |
1 |
|
femur - pathology - radiography |
1 |
|
fructose-fed rats |
1 |
|
full matrix algebras |
1 |
|
generalized matrix algebras |
1 |
|
ghrelin |
1 |
|
high-fat |
1 |
|
hypertension - physiopathology - prevention and control |
1 |
|
infant adiposity |
1 |
|
intermediary metabolites |
1 |
|
iptakalim |
1 |
|
katp channels - agonists |
1 |
|
knockout mouse |
1 |
|
lean men |
1 |
|
leptin |
1 |
|
leptin receptor |
1 |
|
lie derivations |
1 |
|
lifespan |
1 |
|
lipocalins - physiology |
1 |
|
lipotoxicity |
1 |
|
mct |
1 |
|
mechanical properties |
1 |
|
metabolic syndrome x - metabolism - therapy |
1 |
|
mice, mutant strains |
1 |
|
nad |
1 |
|
obesity - complications - drug therapy |
1 |
|
obesity - metabolism - therapy |
1 |
|
oligomeric assembly |
1 |
|
phenotype |
1 |
|
postprandial |
1 |
|
pregnancy |
1 |
|
premature senescence |
1 |
|
primary endothelial cells |
1 |
|
propylamines - pharmacology |
1 |
|
protein acetylation |
1 |
|
protein–protein interaction |
1 |
|
proto-oncogene proteins - physiology |
1 |
|
receptors, leptin - deficiency - metabolism |
1 |
|
replicative senescence |
1 |
|
saturated fatty acids |
1 |
|
senolytics |
1 |
|
serotonin receptor agonists - adverse effects - pharmacology |
1 |
|
sirt-1 |
1 |
|
sirtuins |
1 |
|
small lipid-binding protein |
1 |
|
spontaneously hypertensive rats |
1 |
|
therapeutic targets |
1 |
|
triangular algebras |
1 |
|
w42a mutant |
1 |